...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
HCA NYSE 🇺🇸 US
HCA Healthcare
Healthcare
Watch
Price Zone: Buy Zone
🔒 Full AI Analysis — Pro
44Score
DipBuster Score™
$400.73 $5.88 (0%) Live price · Source: FMP-live
52-Week Position
$353.99 23% of range $556.52
Dividend
no income
Mkt Cap
$86.76B
total value
Mkt Cap$86.76B
P/EN/A
DividendNone
BetaN/A
52W High$556.52
52W Low$353.99
DipBuster Brief Key signals at a glance
Zone: Buy Zone
Bullish
Near 52-Week Low — Wide Margin of Safety
At 23% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio
Mkt Cap$86.76B
52W Position23% of range
EV/EBITDA
Cash Flow
FCF Yield
FCF / Share
Op. Cash Flow
Margins
Gross Margin
Op. Margin
Net Margin
Balance Sheet
Cash
Total Debt
Net Cash
Dividend
Yield
Annual / shNone
Beta
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at HCA Healthcare (HCA), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-05-07 Marks Mike A BUY 3,336
2026-05-07 Marks Mike A SELL 3,336
2026-04-28 Smith Andrea B BUY 509
2026-04-28 Frist William R BUY 809
2026-04-28 Riley Wayne Joseph BUY 509
2026-04-28 Johnston Hugh F BUY 809
2026-04-28 Frist Thomas F Iii BUY 1,041
2026-04-28 Michelson Michael W BUY 925
2026-04-28 Deparle Nancy Ann BUY 509
2026-04-28 Chidsey John BUY 809

Valuation

P/E RatioN/A
Market Cap$86.76B
BetaN/A
Dividend/yrNone
52W High$556.52
52W Low$353.99

52-Week Range

$353.99Now$556.52
23% through annual range
From 52W High−28%
From 52W Low+13.2%
📖 Plain English Summary
HCA Healthcare is at 23% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for HCA 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — HCA
Heuristic · balance sheet, insider filings, price data, academic research

HCA Healthcare — DipBuster Score 44/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track HCA Healthcare free

Add HCA to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Open Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 31/25
Momentum & Volume 8/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
11 /100 · NEUTRAL
dip depth 11/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 44/100
📊 Run a full check in the AI analysis tab for a deeper look.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →